Elanco Animal Health Incorporated (FRA:5EA)

Market Cap	9.97B
Revenue (ttm)	3.91B
Net Income (ttm)	30.68M
Shares Out	n/a
EPS (ttm)	0.06
PE Ratio	324.97
Forward PE	24.35
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	1,257
Open	19.19
Previous Close	n/a
Day's Range	19.19 - 19.90
52-Week Range	7.49 - 21.90
Beta	n/a
RSI	65.48
Earnings Date	Feb 24, 2026

About Elanco Animal Health

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 9,450
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5EA

Financial Performance

Financial numbers in USD